Administrative Core

行政核心

• 批准号: 10625687
• 负责人: Dana Borden Lacy
• 金额: $ 5.23万
• 依托单位: VANDERBILT UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-03-03 至 2028-02-29
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10625687
• 关键词: Academic Medical Centers; Antibodies; Antigens; Clostridium difficile; Communities; Complex; Data; Ensure; Feedback; Fostering; Goals; Human Resources; Institution; Intellectual Property; Leadership; Link; Monitor; Mucosal Immunity; National Institute of Allergy and Infectious Disease; Notification; Productivity; Reagent; Reporting; Research; Research Personnel; Resources; Science; Technology Transfer; Travel; United States National Institutes of Health; Vaccines; commercialization; enteric infection; experience; improved; meetings; member; programs; public database; success

ADMINISTRATIVE CORE PROJECT SUMMARY The Administrative Core for the Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines (VANDy-CdV) program will serve to integrate and facilitate the broad range of activities that will be undertaken within the program. This core will benefit from considerable administrative leadership experience among the team members as well as strong institutional support. Four specific aims/responsibilities are proposed. The first aim will be to coordinate program activities. The success of VANDy-CdV will depend on frequent and meaningful interactions between all investigators. A Local Steering Committee composed of project leaders, core directors, and key personnel will meet monthly to monitor progress, guide scientific directions, and to monitor finance- and compliance-related issues. In addition, a full team meeting will occur quarterly to foster productive and collaborative research. All VANDy-CdV members will be invited to share progress and solicit constructive feedback. The Administrative Core will plan, coordinate, and document the activities from these meetings. The second aim will be to interface with NIAID Program Officers and ensure that NIH reporting requirements are met. In addition to official reporting requirements, the Administrative Core will notify the NIH of all VANDy-CdV monthly and quarterly meetings. The Core will generate reports following each meeting and distribute these reports to Local Steering Committee leaders and NIAID Program Officers. The Administrative Core will also coordinate travel for VANDy-CdV members to attend and participate in Annual Programmatic Meetings. The third aim is to provide fiscal oversight. Vanderbilt University Medical Center is ultimately responsible for all spending decisions involving VANDy-CdV; however, the initial level of fiscal oversight will be the responsibility of the Administrative Core. The fourth aim is to manage intellectual property, resource and reagent distribution, and transmittal of data to public databases. Opportunities relating to intellectual property across the projects and cores will be handled by the Administrative Core in conjunction with the Vanderbilt Center for Commercialization and Technology Transfer (CTTC). The Administrative Core also will ensure that all reasonable requests for reagents from any VANDy-CdV program are satisfied within a timely manner.

行政核心项目摘要 艰难梭菌范德比尔特抗体和抗原发现管理核心 疫苗（VANDy-CdV）计划将有助于整合和促进将在 在计划内进行。这一核心将受益于丰富的行政领导经验 团队成员之间以及强大的机构支持。四个具体目标/责任是 提出了第一个目标是协调方案活动。VANDy-CdV的成功将取决于 所有研究者之间经常进行有意义的互动。地方指导委员会，由项目 领导人、核心主任和关键人员将每月开会，监测进展情况，指导科学方向， 监测与财务和合规有关的问题。此外，每季度将举行一次全体团队会议， 生产和合作研究。所有VANDy-CdV成员将被邀请分享进展并征求 建设性反馈行政核心将计划、协调和记录这些活动， 会议.第二个目标是与NIAID项目官员互动并确保NIH报告 要求得到满足。除了官方报告要求外，行政核心还将通知NIH 所有VANDy-CdV月度和季度会议。核心小组将在每次会议后编写报告， 将这些报告分发给地方指导委员会领导人和NIAID项目官员。行政 核心还将协调旅行VANDy-CdV成员出席和参加年度计划 会议.第三个目标是提供财政监督。范德比尔特大学医学中心最终 负责所有涉及VANDy-CdV的支出决定;然而，最初的财政监督水平将是 行政核心的责任。第四个目标是管理知识产权、资源和 试剂分配和向公共数据库传输数据。与知识产权有关的机会 跨项目和核心的工作将由行政核心与范德比尔特中心共同处理 商业化和技术转让（CTTC）。行政核心还将确保所有 及时满足任何VANDy-CdV项目对试剂的合理要求。